Sivem Pharmaceuticals ULC — licence 101965, currently licensed, last inspection rating C (2025-02-04).
No Canadian shortage report is currently matched to this DIN.
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02291878 | ACT ENALAPRIL | TEVA CANADA LIMITED | Tablet | ENALAPRIL SODIUM (ENALAPRIL MALEATE) 2 MG | Marketed |
| 02291908 | ACT ENALAPRIL | TEVA CANADA LIMITED | Tablet | ENALAPRIL SODIUM (ENALAPRIL MALEATE) 16 MG | Marketed |
| 02291894 | ACT ENALAPRIL | TEVA CANADA LIMITED | Tablet | ENALAPRIL SODIUM (ENALAPRIL MALEATE) 8 MG | Marketed |
| 02291886 | ACT ENALAPRIL | TEVA CANADA LIMITED | Tablet | ENALAPRIL SODIUM (ENALAPRIL MALEATE) 4 MG | Marketed |
| 02442981 | ENALAPRIL | SIVEM PHARMACEUTICALS ULC | Tablet | ENALAPRIL SODIUM (ENALAPRIL MALEATE) 16 MG | Marketed |
| 02442957 | ENALAPRIL | SIVEM PHARMACEUTICALS ULC | Tablet | ENALAPRIL SODIUM (ENALAPRIL MALEATE) 2 MG | Marketed |
| 02442965 | ENALAPRIL | SIVEM PHARMACEUTICALS ULC | Tablet | ENALAPRIL SODIUM (ENALAPRIL MALEATE) 4 MG | Marketed |
| 00657298 | VASERETIC | ORGANON CANADA INC. | Tablet | ENALAPRIL SODIUM (ENALAPRIL MALEATE) 8 MG; HYDROCHLOROTHIAZIDE 25 MG | Marketed |
| 00670901 | VASOTEC | ORGANON CANADA INC. | Tablet | ENALAPRIL SODIUM (ENALAPRIL MALEATE) 8 MG | Marketed |
| 00708879 | VASOTEC | ORGANON CANADA INC. | Tablet | ENALAPRIL SODIUM (ENALAPRIL MALEATE) 4 MG | Marketed |
| 00670928 | VASOTEC | ORGANON CANADA INC. | Tablet | ENALAPRIL SODIUM (ENALAPRIL MALEATE) 16 MG | Marketed |